CG Oncology Corp (CGON): Company Cash Funds

Graphic logo of CG Oncology, Inc. (CGON)

Despite clinical inertia, CG Oncology, Inc. (CGON) is striving toward a stage of stable profitability. The cash reserve history confirms liquidity, where the value of 0.98 serves as the baseline indicator. Risks are mitigated by the drug Cretostimogene, which offers an organ-sparing approach. The use of oncolytic viruses to destroy late-stage tumors enables the company's expansion into the open market.

Company Cash Funds: CG Oncology Corp (CGON) for 02/21/2024 - 11/21/2026

CGON (CG Oncology Corp): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
- stock exchange capitalization data:
Analysis of all company metrics:CG Oncology, Inc. CGON
Brand item of CG Oncology Inc

This indicator measures the volume of liquid assets, serving as a guarantee of solvency and protection against cash flow gaps during periods of market volatility. By analyzing the cash reserve metric on the GURU.Markets platform, investors assess the ability of CG Oncology, Inc. (CGON) to fund the development of targeted biologics until mass insurance payouts for bladder cancer treatment commence.

Direct competitors

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|URGN - Company Cash Funds|Bicara Bio - Company Total Cash Amount|PSNL: Company Cash Volume|Company Cash and Cash Equivalents ERAS|Company Cash on Hand DCTH|Company Cash Reserve Y-mAbs Therapeutics Inc YMAB|Company Cash Volume AURA|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds